Bone alterations in hepatitis C virus infected patients

Area of Science:

• Hepatology
• Endocrinology
• Bone Metabolism

Background:

• Osteoporosis is frequently associated with chronic hepatitis C virus (HCV) infection.
• The roles of liver function impairment and nutritional status in bone alterations remain unclear.
• Some studies report no osteoporosis or even osteosclerosis in HCV patients.

Purpose of the Study:

• To investigate bone alterations in treatment-naïve, well-nourished HCV patients.
• To determine if HCV infection directly causes osteoporosis, independent of liver function and nutrition.
• To differentiate the effects of HCV from other factors influencing bone health.

Main Methods:

• Whole-body bone densitometry (BMD, T-score) in 40 HCV patients and 40 controls.
• Nutritional assessment (BMI, lean/fat mass) and liver biopsy in all patients.
• Biochemical analysis of bone turnover markers, hormones (IGF-1, testosterone), and vitamin D3.

Main Results:

• No significant differences in total BMD or T-scores between HCV patients and controls.
• HCV patients exhibited lower IGF-1, vitamin D3, and testosterone levels.
• Higher telopeptide levels and a trend towards higher osteoprotegerin were observed in patients.
• Age, sex, and lean mass were the sole independent predictors of BMD.

Conclusions:

• Chronic HCV infection in well-nourished individuals with preserved liver function does not cause osteoporosis.
• Bone alterations in HCV patients may be influenced by factors other than the virus itself.
• Further research is needed to elucidate the complex relationship between HCV and bone metabolism.